About: Piloting the Clinical Value of Wearable Cardiorespiratory Monitoring for People with Cystic Fibrosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Piloting the Clinical Value of Wearable Cardiorespiratory Monitoring for People with Cystic Fibrosis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Piloting the Clinical Value of Wearable Cardiorespiratory Monitoring for People with Cystic Fibrosis
Creator	Brussels, Belgium Antwerp, Belgium Chmiel, James Cystic, D Europe, Fibrosis Roesch F,G A Byteflies, Erica Storms, Valerie Van Den Bergh, Bertold Vandendriessche, Benjamin
Source	MedRxiv
abstract	Introduction. Cystic Fibrosis (CF) is a disease without a primary cure that requires lifelong care and is characterized by pulmonary exacerbations (PEx). Wearable devices could provide a way for long-term monitoring of disease progression and early signs of PEx to intervene as early as possible, thereby improving long-term outcomes. Methods. In-hospital feasibility study (n = 26) to 1) assess the ability of Byteflies Sensor Dot to collect relevant cardiorespiratory data in people with CF and its compatibility with clinical workflows, 2) identify candidate digital biomarkers, and 3) collect user feedback from patients and healthcare providers. Results. Collected sample-level biopotential, bioimpedance and actigraphy data were of high quality. Sensor Dot heart rate (HR) correlated with hospital HR, whereas respiratory rate (RR) did not. HR and RR were associated with CF severity, and HR and coughing with PEx. Willingness to use the device was very high with CF patients and study coordinators considered the device easy-to-use. Conclusion. Determining if a wearable is fit-for-purpose is a long and multidisciplinary process that requires involvement from all stakeholders as early as possible in the development process. Our pilot identified interesting correlations between cardiorespiratory parameters as measured by the wearable, and CF severity and PEx. Together with the usability data, this will inform the next steps in the clinical development process.
has issue date	2020-08-04(xsd:dateTime)
bibo:doi	10.1101/2020.07.27.20151589
has license	medrxiv
sha1sum (hex)	cf5d23a4d7b80473c28d31330b81b6dc79dab632
schema:url	https://doi.org/10.1101/2020.07.27.20151589
resource representing a document's title	Piloting the Clinical Value of Wearable Cardiorespiratory Monitoring for People with Cystic Fibrosis
resource representing a document's body	covid:cf5d23a4d7b80473c28d31330b81b6dc79dab632#body_text
is schema:about of	named entity 'PEx' named entity 'improving' named entity 'OUTCOMES' named entity 'pulmonary' named entity 'cure' named entity 'intervene' named entity '2, 3' named entity 'peer review' named entity 'clinical setting' named entity 'FEV1' named entity 'accelerometer' named entity 'Rainbow Babies and Children's Hospital' named entity 'modulator therapies' named entity 'ECG' named entity 'quality control' named entity 'healthcare professionals' named entity 'FEV1' named entity 'biomarker' named entity 'spirometry' named entity 'Physiologic' named entity 'long-term' named entity 'heterogeneity' named entity 'ECG' named entity 'medRxiv' named entity 'morbidity' named entity 'gene' named entity 'Vital Signs' named entity 'heart rate' named entity 'peer review' named entity 'medRxiv' named entity 'cough' named entity 'peer review' named entity 'ECG' named entity 'respiratory volume' named entity 'peer review' named entity 'blood pressure' named entity 'ECG' named entity 'electrode' named entity 'medRxiv' named entity 'cough' named entity 'convolutional neural network' named entity 'data quality' named entity 'ECG' named entity 'peer review' named entity 'cough' named entity 'respiration' named entity 'Cystic Fibrosis' named entity 'medRxiv' named entity 'biomarker' named entity 'vital sign' named entity 'medRxiv' named entity 'ECG' named entity 'non-significant' named entity 'REDCap' named entity 'spline interpolation' named entity 'physical activity' named entity 'peer review' named entity 'medRxiv' named entity 'UHCMC' named entity 'correction for multiple comparisons' named entity 'FEV1' named entity 'thorax' named entity 'peer review' named entity 'user experience' named entity 'Poincaré plot' named entity 'medRxiv' named entity 'Linear regression' named entity 'inpatient and outpatient' named entity 'medRxiv' named entity 'algorithm' named entity 'user experience' named entity 'Medical wearables' named entity 'bioimpedance' named entity 'UHCMC' named entity 't-test' named entity 'Cystic Fibrosis' named entity 'coughing'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software